These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31600416)

  • 1. Evaluation of a 0.75 × 10
    Bisson JL; Fournier Q; Johnston E; Handel I; Bavcar S
    Vet Comp Oncol; 2020 Sep; 18(3):258-268. PubMed ID: 31600416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.
    Fournier Q; Serra JC; Handel I; Lawrence J
    J Vet Intern Med; 2018 Jan; 32(1):384-393. PubMed ID: 29205493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial use in the veterinary cancer patient.
    Boudreaux B
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):883-91. PubMed ID: 25174905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
    Wittenburg LA; Weishaar K; Ramirez D; Gustafson DL
    Vet Comp Oncol; 2019 Jun; 17(2):147-154. PubMed ID: 30638304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendations.
    Bisson JL; Argyle DJ; Argyle SA
    Vet Comp Oncol; 2018 Sep; 16(3):301-310. PubMed ID: 29892997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).
    Britton BM; Kelleher ME; Gregor TP; Sorenmo KU
    Vet Comp Oncol; 2014 Dec; 12(4):266-76. PubMed ID: 22998454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial prophylaxis is considered sufficient to preserve an acceptable surgical site infection rate in clean orthopaedic and neurosurgeries in dogs.
    Välkki KJ; Thomson KH; Grönthal TSC; Junnila JJT; Rantala MHJ; Laitinen-Vapaavuori OM; Mölsä SH
    Acta Vet Scand; 2020 Sep; 62(1):53. PubMed ID: 32943076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Sutheesophon J; Sutcharitchan P; Swasdikul D
    Leuk Lymphoma; 2000 Apr; 37(3-4):351-60. PubMed ID: 10752986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
    J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of febrile neutropenic episodes in paediatric oncology at the Wendy Fitzwilliam Paediatric Hospital.
    Timothy M; Bodkyn C
    West Indian Med J; 2011 Mar; 60(2):153-7. PubMed ID: 21942119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of the management of neutropenic fever in oncology units in the UK.
    Ziglam HM; Gelly K; Olver W
    Int J Antimicrob Agents; 2007 Apr; 29(4):430-3. PubMed ID: 17293091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF in solid tumor chemotherapy: a tailored regimen reduces febrile neutropenia, treatment delays and direct costs.
    Tsavaris N; Kosmas C; Gouveris P; Vadiak M; Dimitrakopoulos A; Karadima D; Pagouni E; Panagiotakopoulos G; Tzima E; Ispoglou S; Sakelariou D; Koufos C
    Med Sci Monit; 2004 Feb; 10(2):PI24-8. PubMed ID: 14737055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
    Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
    Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
    Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
    Vanderpuye V; Yarney J; Beecham K
    West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
    Aarts MJ; Vriens BE; de Boer M; Peters FP; Mandigers CM; Dercksen MW; Stouthard JM; Tol J; van Warmerdam LJ; van de Wouw AJ; Jacobs EM; van der Rijt CCD; Smilde TJ; van der Velden AW; Peer N; Tjan-Heijnen VCG
    Oncology; 2017; 93(5):323-328. PubMed ID: 28848182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial evaluation of neutrophil function in tumour-bearing dogs undergoing chemotherapy.
    LeBlanc AK; LeBlanc CJ; Rohrbach BW; Kania SA
    Vet Comp Oncol; 2015 Mar; 13(1):20-7. PubMed ID: 23331512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.